Clinical Trial Update: Innovative Pulmonary Solutions (IPS) System for Targeted Lung Denervation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for the Innovative Pulmonary Solutions System targeting lung denervation in chronic obstructive pulmonary disease; the study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Nuvaira, Inc. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Status: COMPLETED